Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TSM vs GSK✓SelectedUSD · GSKTSM vs GSK performance historyLatest closeAs of-6.34%11/16
Stock and ETF performance explorer

TSM vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+290.3%
GSK return
+62.7%
Excess return
+227.7%
Maximum drawdown
-36.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-6.3%-0.1%-6.3%-6.3%
7D-3.9%-1.3%-2.6%-3.9%
30D-9.5%+2.7%-12.2%-9.4%
3M-12.2%+2.7%-14.9%-12.1%
6M-7.2%+3.3%-10.5%-7.3%
YTD+23.9%+6.5%+17.4%+23.9%
1Y+32.5%+10.7%+21.8%+32.3%
All+290.3%+62.7%+227.7%+280.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling